Objective: To review the currently available data of photodynamic ther
apy (PDT) optical dosimetry for possible prostatic applications, Summa
ry Background Data: PDT is a new cancer treatment modality often used
as an alternative tumor treatment method. Recently, PDT has been sugge
sted as an alternative therapy for prostatic carcinoma and BPH, Method
s: PDT utilizes light and a preadministered photosensitizer drug to ac
hieve localized tumor control, This article reviews currently availabl
e data on optical dosimetry of PDT in both human and canine prostates.
Results: At 630 nm, a common wavelength used for Photofrin PDT, resul
ts indicate that light penetration is similar in cancerous and normal
prostatic tissue. Because of limited light penetration, multiple fiber
irradiation is necessary if eradicating the entire prostate gland is
the ultimate goal. The available data also show that dynamic changes o
ccur in light fluence rate distribution during PDT irradiation. Conclu
sions: PDT can be used to destroy prostatic tissue, Real-time optical
dosimetry is necessary if accurate lesion volume control is desired.